Bibliography
- Blythman HE, Casellas P, Gros O, et al. Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumor cells. Nature 1981: 290(5802): 145–6
- Dillman RO, Shawler DL, Sobol RE, et al. Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia Blood 1982: 59(5): 1036–45
- Gilliland DG, Steplewski Z, Collier RJ. et al. Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells. Proc Natl Acad Sci 1980: 77(8): 4539–43
- Goldenberg DM, DeLand FH. History and status of tumor imaging with radiolabeled antibodies. J Biol Response Mod 1982: 1: 121
- Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975: 256(5517): 495–7
- Miller RA, Maloney DG, McKillop J, et al. In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood 1981: 58(1): 78–86
- Miller RA, Maloney DG, Warlike R, et al. Treatment of B cell lymphoma with monoclonal anti-idiotype antibody. N Engl J Med 1982; 306(9): 517–22
- Neville DM Jr, Youle RJ. Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy. Immunol Rev 1982: 62: 75–91
- Ritz J, Schlossman SF. Utilization of monoclonal antibodies in treatment of leukemia and lymphoma. Blood 1982: 59(1): 1–11
- Rogers GT, Rawlins GA, Bagshawe KD. Somatic-cell hybrids producing antibodies against CEA. Br J Cancer 1981;43(1): 1–4
- Raffeld M, Neckers L, Longo DL, et al. Spontaneous alteration of idiotype in a monoclonal B-cell lymphoma: escape from detection by anti-idiotype. N Engl J Med 1985: 312(26): 1653–8